Modulation of excitable tissue function by peripherally administered erythropoietin

Modulation of excitable tissue function by peripherally administered erythropoietin

  • CN 1,607,957 B
  • Filed: 04/13/2000
  • Issued: 10/10/2012
  • Est. Priority Date: 04/13/1999
  • Status: Active Grant
First Claim
Patent Images

1. one kind is suitable for modulating and stress organizes, strengthens cognitive function or transport the pharmaceutical composition that chemical compound passes the dosage unit form of the tight contact of endothelium;

  • Every dosage unit comprises about 150 of effective nontoxic amount;

    EPO and pharmaceutically acceptable carrier in 000 to 500, the 000 unit scope.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×